Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease

World Journal of Gastroenterology

Volumn 13, Issue 29, 2007, Pages 3985-3989

  Gueimonde, Miguel ^a,b   Ouwehand, Arthur ^a,c   Huhtinen, Heikki ^d   Salminen, Eeva ^d   Salminen, Seppo ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^c Department of Health and Nutrition ^*  (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bifidobacterium; Colonic mucosa; Colorectal cancer; Diverticulitis; Inflammatory bowel disease

Indexed keywords

BACTERIAL DNA;

ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIALES; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM LONGUM; CLINICAL ARTICLE; COLON FLORA; COLON MUCOSA; COLORECTAL CANCER; DIVERTICULITIS; DNA EXTRACTION; ENTERITIS; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

EID: 34547989132     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i29.3985     Document Type: Article

References (31)

1. Gronlund MM, Arvilommi H, Kero, P, Lehtonen OP, Isolauri E. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch Dis Child Fetal Neonatal Ed 2000; 83: F186-F192
2. Kirjavainen PV, Apostolou E, Arvola T, Salminen SJ, Gibson GR, Isolauri E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001; 32: 1-7
3. Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998; 62: 1157-1170
4. Salminen SJ, Gueimonde M, Isolauri E. Probiotics that modify disease risk. J Nutr 2005; 135: 1294-1298
5. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-519
6. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107: 129-134
7. Benno P, Alam M, Henriksson K, Norin E, Uribe A, Midtvedt T. Abnormal colonic microbial function in patients with rheumatoid arthritis. Scand J Rheumatol 1994; 23: 311-315
8. Malin M, Verronen P, Mykkanen H, Salminen S, Isolauri E. Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora? Br J Rheumatol 1996; 35: 689-694
9. Stebbings S, Munro K, Simon MA, Tannock G, Highton J, Harmsen H, Welling G, Seksik P, Dore J, Grame G, Tilsala-Timisjarvi A. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology (Oxford) 2002; 41: 1395-1401
10. Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004; 10: 1802-1805
11. Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 373-382
12. Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 1997; 42: 817-822
13. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55: 205-211
14. Hope ME, Hold GL, Kain R, El-Omar EM. Sporadic colorectal cancer - role of the commensal microbiota. FEMS Microbiol Lett 2005; 244: 1-7
15. Colecchia A, Sandri L, Capodicasa S, Vestito A, Mazzella G, Staniscia T, Roda E, Festi D. Diverticular disease of the colon: new perspectives in symptom development and treatment. World J Gastroenterol 2003; 9: 1385-1389
16. He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001; 30: 43-47
17. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Dore J. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003; 52: 237-242
18. Mylonaki M, Rayment NB, Rampton DS, Hudspith BN, Brostoff J. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 481-487
19. Gueimonde M, Salminen S. Methods for analysing gut microbiota. In: Salminen S, von Wright A, Ouwehand A. Lactic acid bacteria, Microbiological and Functional aspects 3rd edition. New York: Marcel Dekker, 2004: 365-374
20. Ouwehand AC, Salminen S, Arvola T, Ruuska T, Isolauri E. Microbiota composition of the intestinal mucosa: association with fecal microbiota? Microbiol Immunol 2004; 48: 497-500
21. Gueimonde M, Tolkko S, Korpimaki T, Salminen S. New real-time quantitative PCR procedure for quantification of bifidobacteria in human fecal samples. Appl Environ Microbiol 2004; 70: 4165-4169
22. Rinne MM, Gueimonde M, Kalliomaki M, Hoppu U, Salminen SJ, Isolauri E. Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol Med Microbiol 2005; 43: 59-65
23. Gueimonde M, Debor L, Tölkkö S, Jokisalo E, Salminen S. Quantitative assessment of faecal bifidobacterial populations by real-time PCR using lanthanide probes. J Appl Microbiol 2007; 102; 1116-1199
24. Delgado S, Suarez A, Mayo B. Identification of dominant bacteria in feces and colonic mucosa from healthy Spanish adults by culturing and by 16S rDNA sequence analysis. Dig Dis Sci 2006; 51: 744-751
25. Poxton IR, Brown R, Sawyerr A, Ferguson A. Mucosa-associated bacterial flora of the human colon. J Med Microbiol 1997; 46: 85-91
26. Geier MS, Butler RN, Howarth GS. Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer? Cancer Biol Ther 2006; 5: 1265-1269
27. Macfarlane S, Furrie E, Cummings JH, Macfarlane GT. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin Infect Dis 2004; 38: 1690-1699
28. Di Caro S, Tao H, Grillo A, Elia C, Gasbarrini G, Sepulveda AR, Gasbarrini A. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis 2005; 37: 320-329
29. Guandalini S. Use of Lactobacillus-GG in paediatric Crohn's disease. Dig Liver Dis 2002; 34 Suppl 2: S63-S65
30. Gosselink MP, Schouten WR, van Lieshout LM, Hop WC, Laman JD, Ruseler-van Embden JG. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis Colon Rectum 2004; 47: 876-884
31. Giaccari S, Tronci S, Falconieri M, Ferrieri A. Long-term treatment with rifaximin and lactobacilli in post-diverticulitic stenoses of the colon. Riv Eur Sci Med Farmacol 1993; 15: 29-34